fbpx
FOR THE FIRST TIME AVAILABLE TO THE PUBLIC FOR FREE!

9 Thought Provoking Discussions That Could Shape The Future of the Bioeconomy

Join the Bioeconomy Revolution - Get Free Access now

Where is The Bioeconomy Heading?

Synbiobeta-top-9-conversation-bioeconomy
 For the first time ever, SynBioBeta is giving you access to 9 of the most important conversations happening now in synthetic biology. These thought provoking discussions — which were previously exclusive to event attendees — are now available to the public for free for a very limited time.

Hear from key thought leaders like Tristan Harris (Netflix’s The Social Dilemma), George Church (Professor of Genetics at Harvard Medical School) and Jane Metcalfe (CEO of Neolife) about the promise and challenges of creating a better world through biology.

Don’t wait to join the conversations shaping the future of the bioeconomy! Learn where the biology revolution is headed next.
dopamine lite bioeconomy hub

Dopamine, Disinformation, and the Ethics of Technological Progress

What happens when the technology of social media meets the biology of our minds? In this Leaps Talk, SynBioBeta Founder and CEO, John Cumbers, interviews Tristan Harris, popularly known for his work in the critically acclaimed Netflix documentary, the Social Dilemma. Harris, a former design ethicist at Google, offers insights and advice on how the synthetic biology community can avoid the disastrous mistakes of Big Tech.

Conscious Capitalism? Doing Good in the World With Biology

Synthetic biology has the potential to positively impact human lives. But how can we consciously guide the bioeconomy toward market successes that promote human and planetary well-being? This panel explores how innovators and investors can empower each other to make positive changes in the world while developing the biotech community’s awareness of what it means to “do good” in our society.
conscious lite-bioeconomy
pharma lite-bioeconomy

Pharma, Meet SynBio: Five Companies That Are Accelerating Therapies and Vaccines

Computation, automation, and the ease of DNA read/ write/ edit are poised to transform biopharma. Synthetic biology brings these technologies together to provide new platforms for drug discovery and production. In the middle of a pandemic, these biotech advances are more important than ever. Hear in-depth insights into five companies that are transforming biopharma R&D in the coming bioeconomy.

You will also get access to:

The Culture of Synthetic Biology: Moonshots for a Better World


In this Leaps Talk, Kira Peikoff moderates a conversation with George Church and D. A. Wallach about some of the most far-reaching goals of synthetic biology. Learn about the possibilities and be inspired to dream a little (or a lot) bigger.

Beyond Sustainability: Achieving a Truly Circular Carbon Economy


Bio-based products are good, a closed-loop system is better. To tackle climate change, companies are already repurposing carbon as a feedstock in their pipelines. Hear our experts discuss the role of investors and policymakers in realizing a carbon negative future.

Building Consumer Brands: What Are the Challenges?


Building consumer brands with synthetic biology offers incredible promise; however, there are challenges and risks to be managed. This panel explores the possibilities and perils of using synthetic biology in consumer products.

Consumer Biotechnology: Why Now?


Consumer acceptance is critical for the success of biotech products. How do we avoid the mistakes of the past? How can we leverage storytelling to increase broad interest and move beyond the "synbio echo chamber"?

Cell Culture and the Future of Food


Cellular agriculture promises a more sustainable and humane alternative to today’s livestock agricultural system. In this panel, our experts discuss the technical and economical challenges in realizing this vision. Learn more about the latest alt-meat breakthroughs and market insights.

SynBioBeta 2020 Investor Panel


How are investors viewing the synthetic biology industry in the middle of a pandemic? Four leading investors share their advice for innovators, their outlook on the immediate future of the industry and our economy, and the most promising opportunities they see right now.

Join the most important synthetic biology conversations of tomorrow.

GET FREE ACCESS TO THE 9 VIDEOS

Keynotes


Dopamine, disinformation, and the pursuit of science

A Leaps Talk with Tristan Harris on shaping human progress through biology
Tristan Harris is a design ethicist and critic of how the web is downgrading humanity. In this fireside chat with SynBioBeta founder John Cumbers, Harris will explore how the synthetic biology community ought to think about this digital moment in history. What happens when the technology of social media meets the biology of our minds? How does this color the public conversation around tackling global challenges like hunger, genetic disease, and climate change? Learn how tech and biology work for and against us in building a better world with biology.
FOLLOWED BY LIVE Q&A

Technology, culture, and forging audacious aims for our future

A Leaps Talk with George Church, DA Wallach & Kira Peikoff
In a time of COVID, climate-induced wildfires, and political division, how do we keep researchers and the public united to tackle humanity’s most pressing problems?? This conversation brings together a synthetic biology pioneer, an iconoclastic artist/entrepreneur, and a science journalist/bioethicist to explore the technological and cultural trends shaping biotechnology today. We’ll explore the most promising biotech tools for future-proofing humanity, how entrepreneurs and start-ups are catalyzing progress, and our obligations to one another in a shared vision for our biological future.
FOLLOWED BY LIVE Q&A